Cannabis Bioscience International Holdings, Inc. (CBIH) stock
CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31
$0.00+0.00 (+33.33%)
Close on Oct 19, 2026Market cap $2.33MP/E –Yield –
Cannabis Bioscience International profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Cannabis Bioscience International's profit margin for the twelve months ending Feb 28, 2026 was -416.8%. For fiscal 2025 it was -181.1%, against -261.8% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | May 31, 2025 | -181.1% | +80.6 |
| FY2024 | May 31, 2024 | -261.8% | +64.2 |
| FY2023 | May 31, 2023 | -325.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -927.6% | +286.3 |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -219.6% | −112.5 |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -341.5% | −298.9 |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -605.7% | −426.6 |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -1213.9% | −639.3 |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -107.1% | +88.1 |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -42.7% | +207.0 |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -179.2% | +415.5 |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -574.5% | +58.9 |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -195.2% | +71.1 |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -249.6% | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | -594.7% | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -633.4% | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -266.3% | – |
See a number that looks wrong?